GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: Compound 17B [WO2023178099]
Compound class:
Synthetic organic
Comment: The chemical structure for this compound was obtained from WHO INN proposed list 134 (Feb 2026), in which it is described as a NOD-like receptor pyrin domain-containing 3 (NLRP3) inflammasome inhibitor with potential as a non-steroidal anti-inflammatory agent. It is one of the structures claimed in Zomagen Biosciences' (now part of Eli Lilly via a previous Ventyx Biosciences merger) patent WO2023178099 [1]. Evidence suggests that parunoflast is likely the INN for the CNS-penetrant NLRP3 inhibitor VTX3232.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| 2-[6-[(R)-hydroxy-[(3R)-1-methylpiperidin-3-yl]methyl]-4-methylpyridazin-3-yl]-5-(trifluoromethyl)phenol |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 13982 | parunoflast |
Synonyms ![]() |
| Compound 17B [WO2023178099] |
Database Links ![]() |
|
| CAS Registry No. | 2982797-42-0 (source: WHO INN record) |
| PubChem CID | 169066851 |
| Search Google for chemical match using the InChIKey | RWDYJVRIDGIICC-KZULUSFZSA-N |
| Search Google for chemicals with the same backbone | RWDYJVRIDGIICC |
| Search PubMed clinical trials | parunoflast |
| Search PubMed titles | parunoflast |
| Search PubMed titles/abstracts | parunoflast |
| UniChem Compound Search for chemical match using the InChIKey | RWDYJVRIDGIICC-KZULUSFZSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | RWDYJVRIDGIICC-KZULUSFZSA-N |